Our campaign aimed to inform  the wide public, the medical community and the pharmacists about  the mucolytics and to remind  ambroxol, to differentiate the mucolytics from antitussives and to finally to educate the wide public about ambroxol (Mucosolvan)

Our strategic approach was KOL’s relations program, detailing to HCPs (doctors and pharmacists), advertisements in trade and lay media , consensus meetings,  participation in congresses and use all the tools of Press Office.

After 2 years we succeeded  to inform both wide public and HCPs 100% resulting to be Mucosolvan of Boehringer-Ingelheim  first in ranking.